| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 988 | 26 | 1357 | 89 | 1084 | 199 | 1211 |
| ERLYTX | 91 | 1 | 52 | 3 | 37 | 10 | 61 |
| GI | 192 | 4 | 209 | 15 | 183 | 28 | 170 |
| GU | 438 | 2 | 104 | 29 | 353 | 69 | 420 |
| LEUK | 142 | 4 | 209 | 13 | 158 | 27 | 164 |
| LUNG | 192 | 6 | 313 | 18 | 219 | 34 | 207 |
| LYMPH | 395 | 6 | 313 | 35 | 426 | 64 | 390 |
| MELAN | 277 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 159 | 4 | 209 | 5 | 61 | 15 | 91 |
| MULT | 22 | 3 | 157 | 7 | 85 | 15 | 91 |
| OTHER | 38 | 0 | 0 | 2 | 24 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2941 | 57 | 2975 | 218 | 2654 | 468 | 2847 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 115 | 8 | 417 | 15 | 183 | 33 | 201 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 665 | 15 | 783 | 45 | 548 | 103 | 627 |
| LUNG | 304 | 10 | 522 | 35 | 426 | 63 | 384 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 38 | 2 | 104 | 6 | 73 | 12 | 73 |
| PEOLC | 128 | 5 | 261 | 18 | 219 | 36 | 219 |
| PREV | 214 | 7 | 365 | 22 | 268 | 44 | 268 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 575 | 10 | 522 | 47 | 572 | 100 | 609 |
| Total | 2069 | 57 | 2974 | 191 | 2326 | 398 | 2424 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 988 | 26 | 1357 | 89 | 1084 | 199 | 1211 |
| CCD | 115 | 8 | 417 | 15 | 183 | 33 | 201 |
| ERLYTX | 101 | 1 | 52 | 3 | 37 | 11 | 67 |
| GI | 192 | 4 | 209 | 15 | 183 | 28 | 170 |
| GU | 438 | 2 | 104 | 29 | 353 | 69 | 420 |
| LEUK | 807 | 19 | 991 | 58 | 706 | 130 | 791 |
| LUNG | 496 | 16 | 835 | 53 | 645 | 97 | 590 |
| LYMPH | 396 | 6 | 313 | 35 | 426 | 64 | 390 |
| MELAN | 277 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 159 | 4 | 209 | 5 | 61 | 15 | 91 |
| MULT | 22 | 3 | 157 | 7 | 85 | 15 | 91 |
| OTHER | 76 | 2 | 104 | 8 | 97 | 17 | 103 |
| PEOLC | 128 | 5 | 261 | 18 | 219 | 36 | 219 |
| PREV | 217 | 7 | 365 | 22 | 268 | 44 | 268 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 577 | 10 | 522 | 47 | 572 | 100 | 609 |
| Total | 5010 | 114 | 5948 | 409 | 4980 | 866 | 5270 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 608 | 15 | 783 | 58 | 706 | 128 | 779 |
| ERLYTX | 50 | 1 | 52 | 2 | 24 | 7 | 43 |
| GI | 140 | 3 | 157 | 12 | 146 | 22 | 134 |
| GU | 367 | 2 | 104 | 22 | 268 | 52 | 317 |
| LEUK | 89 | 4 | 209 | 10 | 122 | 17 | 103 |
| LUNG | 122 | 2 | 104 | 7 | 85 | 15 | 91 |
| LYMPH | 252 | 3 | 157 | 25 | 304 | 40 | 244 |
| MELAN | 175 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 104 | 4 | 209 | 5 | 61 | 8 | 49 |
| MULT | 8 | 1 | 52 | 2 | 24 | 5 | 30 |
| OTHER | 38 | 0 | 0 | 2 | 24 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1960 | 36 | 1879 | 147 | 1788 | 301 | 1832 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 102 | 7 | 365 | 14 | 170 | 28 | 170 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 301 | 6 | 313 | 22 | 268 | 47 | 286 |
| LUNG | 187 | 7 | 365 | 22 | 268 | 41 | 250 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 37 | 1 | 52 | 5 | 61 | 11 | 67 |
| PEOLC | 91 | 4 | 209 | 14 | 170 | 29 | 177 |
| PREV | 213 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 387 | 6 | 313 | 29 | 353 | 61 | 371 |
| Total | 1348 | 37 | 1930 | 130 | 1583 | 267 | 1626 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 791 | 18 | 939 | 66 | 804 | 155 | 944 |
| CCD | 131 | 4 | 209 | 13 | 158 | 33 | 201 |
| ERLYTX | 60 | 1 | 52 | 2 | 24 | 8 | 49 |
| GI | 145 | 2 | 104 | 11 | 134 | 24 | 146 |
| GU | 389 | 4 | 209 | 27 | 329 | 57 | 347 |
| LEUK | 390 | 10 | 522 | 32 | 390 | 64 | 390 |
| LUNG | 310 | 9 | 470 | 28 | 341 | 56 | 341 |
| LYMPH | 253 | 3 | 157 | 25 | 304 | 40 | 244 |
| MELAN | 175 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 100 | 4 | 209 | 5 | 61 | 8 | 49 |
| MULT | 22 | 1 | 52 | 2 | 24 | 7 | 43 |
| OTHER | 252 | 4 | 209 | 19 | 231 | 45 | 274 |
| PEOLC | 95 | 3 | 157 | 13 | 158 | 27 | 164 |
| PREV | 216 | 6 | 313 | 21 | 256 | 43 | 262 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 389 | 6 | 313 | 29 | 353 | 61 | 371 |
| Total | 3739 | 76 | 3967 | 298 | 3628 | 636 | 3874 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 836 | 18 | 939 | 70 | 852 | 156 | 950 |
| ERLYTX | 87 | 1 | 52 | 3 | 37 | 9 | 55 |
| GI | 107 | 1 | 52 | 8 | 97 | 17 | 103 |
| GU | 250 | 1 | 52 | 19 | 231 | 45 | 274 |
| LEUK | 108 | 1 | 52 | 8 | 97 | 20 | 122 |
| LUNG | 161 | 6 | 313 | 15 | 183 | 30 | 183 |
| LYMPH | 321 | 6 | 313 | 26 | 317 | 52 | 317 |
| MMYEL | 148 | 4 | 209 | 5 | 61 | 14 | 85 |
| MULT | 22 | 3 | 157 | 7 | 85 | 15 | 91 |
| Total | 2040 | 41 | 2139 | 161 | 1960 | 358 | 2180 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1947 | 42 | 2191 | 173 | 2106 | 348 | 2118 |
| AFFIL | 119 | 5 | 261 | 15 | 183 | 28 | 170 |
| CCOP/NCORP | 1242 | 26 | 1357 | 89 | 1084 | 192 | 1169 |
| Non-SWOG | 1700 | 39 | 2035 | 130 | 1583 | 296 | 1802 |
| Total | 5008 | 112 | 5844 | 407 | 4956 | 864 | 5259 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| MMYEL | S2005 | WM, Prev. Untreated, I/R +/- Venetoclax | 1 | T | 20-NOV-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 15 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 13 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 10 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 10 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 7 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 6 |
| CCD | S1703 | Met Breast, STM-monitoring v Usual Care | 2 | 5 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 5 |
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | 4 |
| PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 4 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 4 |
| MMYEL | S2209 | MM, Newly Dx, VRd-R->R v DRd-R->R v DRD-DR->D | 1 | 4 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 4 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 3 |
| LUNG | S1800E | Non-Match: Docetaxel + Ramu +/- Cemiplimab | 1 | 3 |
| LUNG | S1827 | SCLC, MRI Surveillance +/- PCI | 1 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 2 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 1 | 3 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |